Literature DB >> 27235982

Fusarium spp infections in a pediatric burn unit: nine years of experience.

María Teresa Rosanova1, Martín Brizuela2, Mabel Villasboas3, Fabian Guarracino3, Veronica Alvarez2, Patricia Santos4, Jorge Finquelievich2.   

Abstract

INTRODUCTION: Fusarium spp are ubiquitous fungi recognized as opportunistic agents of human infections, and can produce severe infections in burn patients. The literature on Fusarium spp infections in pediatric burn patients is scarce.
OBJECTIVES: To describe the clinical and epidemiological features as well as outcome of Fusarium spp infections in pediatric burn patients. PATIENTS AND METHODS: Retrospective, descriptive study of Fusarium spp infections in a specialized intensive care burn unit.
RESULTS: In 15 patients Fusarium spp infections were diagnosed. Median age was 48 months. Direct fire injury was observed in ten patients. The median affected burn surface area was 45%. Twelve patients had a full thickness burn. Fourteen patients had a Garces Index ≥3. Fungal infection developed at a median of 11 days after burn injury. Fungi were isolated from burn wound in 14 patients and from the bone in one patient. Amphotericin B was the drug of choice for treatment followed by voriconazole. Median time of treatment completion was 23 days. One patient (7%) died of fungal infection-related causes.
CONCLUSION: In our series Fusarium spp was an uncommon pathogen in severely burnt patients. The burn wound was the most common site of infection and mortality was low.
Copyright © 2016 Elsevier Editora Ltda. All rights reserved.

Entities:  

Keywords:  Burn; Fungal infections; Fusarium spp

Mesh:

Year:  2016        PMID: 27235982      PMCID: PMC9427570          DOI: 10.1016/j.bjid.2016.04.004

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   3.257


Introduction

Infection is the most common and severe cause of morbidity and mortality in burn patients. The longer survival of this population has increased the frequency of fungal infections. The most commonly isolated species is Candida spp and in recent times there has been an increase in filamentous fungi such as Aspergillus spp, Mucor spp, and Fusarium spp. Fusarium spp – a filamentous fungus – is ubiquitous in the environment and can be found in water and in the soil. It mainly produces infections in individuals with immune disorders caused by tumors, use of cytostatics, steroids, presence of diabetes mellitus, and HIV infection among others. Burn patients are the most commonly affected immunocompetent hosts.1, 4 Commonly isolated Fusarium spp are F. solani, F. oxysporum, F. proliferatum, F. verticilliodes, etc. The literature on Fusarium spp infections in pediatric patients with burns is limited. Most publications are case reports of disseminated Fusarium spp infections in cancer patients or fungal keratitis infections.6, 7, 8 The aim of this study was to describe the epidemiological, clinical, and microbiological features as well as outcome of infections due to Fusarium spp in pediatric burn patients.

Patients and methods

This was a retrospective, descriptive and observational study of Fusarium spp infections in a specialized burn intensive care unit between January 2006 and March 2015.

Inclusion criteria

All burn patients with clinical and microbiological evidence of fungal infection by Fusarium spp documented from representative samples, such as deep burn tissue, and/or blood, and/or other sterile sites with positive cultures were included.

Definition

Clinical evidence was defined by local signs of infection such as drainage of pus, redness or swelling at the margin of the burn, scar separation, localized necrosis, vesicular lesions, and/or poor adherence of the graft. Microbiological evidence was defined by the isolation of Fusarium spp in deep tissue samples or sterile materials (blood, purulent materials, and/or urine).

Infection types

Infections were defined according to the American Burn Association: The Garces’ Index – an index of prediction of severity and mortality calculated as follows: 40 − patient age × 1 percentage burn (if type A), ×2 (if type AB), ×3 (if type B). 0–60 points: Grade 1 (slight risk); 61–90 points: Grade 2 (moderate risk); 91–120 points: Grade 3 (severe risk); >121 points: Grade 4 (critical risk).

Depth of burn

Type A: superficial burn with erythema and hyperalgesia; Type AB: pink-white intermediate-color scar, and hypoalgesia; Type B or “full thickness”: deep, white or black scar and analgesia.

Microbiology

In addition to regular bacteriological study, all materials were processed for mycological study.

Results

A total of 15 patients were infected by Fusarium spp during the study period. The mechanism of burn was direct fire in 10 patients (66%), hot liquids in four (27%), and electricity in one case (7%); 87% (n = 13) were male. Median age was 48 months (IQR 12–108 months). The median body surface area burned was 45% (IQR 30–60%). Eighty percent of patients (n = 12) had deep burns (type B); 60% (n = 9) had a Garces’ index of 3, 33% (n = 5) an index of 4, and the remaining 7% (n = 1) an index of 2. The median time from burn injury to onset of fungal infection was 11 days (IQR 4–24 days). All patients had central lines with a median dwell time of 20 days (IQR 12–30). Of all patients, 87% (n = 13) required mechanical ventilation with a median of 16 days (IQR 10–30). The most common site of microbiological isolation was the burn wound in 15 patients (100%) and bone in one patient (7%). In one patient (7%) Fusarium spp was isolated from blood cultures. In 87% of cases (n = 13) concomitant bacterial infections were found. Empirical antifungal treatment was started with amphotericin B deoxycholate in 14 patients (93%) and voriconazole in one patient (7%). All patients were switched to treatment with voriconazole after microbiological isolation of Fusarium spp. Median antifungal treatment was 23 days (IQR 17–42 days). No adverse events related to the use of antifungal agents were reported. The combination of medical treatment using amphotericin B, voriconazole, and surgical removal of infectious foci was effective in all cases. The median length of hospital stay was 55 days (IQR 22–60 days). Only one patient (7%) died, 14 days after admission due to septic shock related to Fusarium spp infection (Table 1, Table 2).
Table 1

Patients characteristics.

VariableN (IQR)Percentage (IQR)
Patients15100
Age48 m (12–108)
Male sex1173
Burn surface45 (30–60)
Garces index >3960
Full thickness1280
Inhalatory injury1173
Mechanical respiratory assistance1387
Central venous catheter15100
Vesical catheter15100
Time between injury and infection11 (4–24)
Concomitant infection with bacteria1387
Time of treatment23 (17–42)
Mortality17
Days of hospitalization55 (22–60)
Table 2

Infection characteristics.

VariablenPercentage
Wounds infection15100
Bloodstream17
Bone17
Patients characteristics. Infection characteristics.

Discussion

Infections remain the leading cause of mortality in burn patients. The use of topical and systemic antimicrobials along with infection-control measures has reduced the incidence of bacterial infections; however, fungal infections have remained stable showing an incidence between 6 and 40% in different series.1, 5, 6 In a previous study conducted at our center we reported on 128 infections in 84 patients of which 53 cases (20%) had a documented fungal etiology. Some risk factors for developing fungal infections in burn patients are extremes of age, large body surface burned (≥40%), inhalation syndrome, requirement for mechanical ventilation, use of broad spectrum antibiotics, prolonged use of central venous and bladder catheters, presence of diabetes mellitus, and parenteral nutrition.2, 3, 10, 11 Progression from fungal colonization to infection of the wound is directly related to the body surface area burned. Therefore, close monitoring of patients with large surfaces burned (≥40%) is recommended to establish early therapeutic measures. Different studies in the literature have reported a higher incidence of fungal infections in more severe burns.1, 3, 4, 6 In this series, the median body surface area burned was 45%, reflecting the severity of the study sample at high risk for the occurrence of fungal infections in line with published literature.6, 10 Candida spp is the most frequently involved species in fungal infections in burns. In recent times the incidence of filamentous fungi such as Aspergillus spp, and to a lesser extent Mucor spp and Fusarium spp, has increased. In a previous study on fungal infections in our center the most frequently isolated fungus was Candida albicans (3.4%). In this study fungal infections occurred from the second week of hospitalization (median 11 days), coinciding with several other reports.2, 3, 11 Fusarium can be isolated by tissue biopsies that may show the presence of filamentous fungi in and around vessels of the dermis, thrombosis, and tissue necrosis. Blood cultures may be positive in 50–70% of cases in immunocompromised host infections.14, 15 The most common site of infection is the burn wound.1, 3, 4, 14 In this study 100% of patients had infection of the burn wound and only one (7%) had bone involvement. Additionally, fungemia was detected in only one patient (7%). Early treatment of localized forms is essential to prevent the spread of Fusarium spp. Mortality rates have been reduced with early debridement of injuries combined with antifungal treatment.15, 16, 17 In our burn unit, amphotericin B deoxycholate or lipid formulations are used as empirical treatment against filamentous fungi. When Fusarium spp is isolated voriconazole is the drug of choice. The total duration of treatment varies according to the extension of the infection. Some studies reported a treatment duration of at least two weeks after the last fungal isolation coinciding with the management approach in our burn unit.2, 11, 18 Mortality due to fungal infections varies between 75 and 90% and is associated with a burned surface area between 40% and 60%.1, 10, 19 Some studies found no difference in mortality rates according to the fungal agent involved. In contrast, the study by Schaal et al. found that patients with Aspergillus spp infections had a 30% mortality whereas none of those infected with Fusarium spp died, in line with the low mortality rate found in our study. Nir Paz et al. reported an 11% mortality rate in Fusarium spp infections in different inmunocompromised patients with a higher risk in patients with burns. In our series, one patient died of septic shock due to infection by Fusarium spp, representing a mortality rate of 7% in the study period, which is lower than that found in the literature.11, 12, 13, 14, 15, 16, 17, 18, 19, 20

Conclusions

Fusarium spp was a rarely isolated pathogen in burned patients in our unit. The burn wound was the most frequent site of isolation. Mortality was low.

Conflicts of interest

The authors declare no conflicts of interest.
  20 in total

1.  Correlation of culture with histopathology in fungal burn wound colonization and infection.

Authors:  Christina M Schofield; Clinton K Murray; Edward E Horvath; Leopoldo C Cancio; Seung H Kim; Steven E Wolf; Duane R Hospenthal
Journal:  Burns       Date:  2007-02-26       Impact factor: 2.744

2.  Changing pattern of fungal infection in burn patients.

Authors:  Sujata Sarabahi; V K Tiwari; Savita Arora; Malini R Capoor; Anurag Pandey
Journal:  Burns       Date:  2011-10-27       Impact factor: 2.744

3.  Fusarium infections of the skin.

Authors:  Aditya K. Gupta; Robert Baran; Richard C. Summerbell
Journal:  Curr Opin Infect Dis       Date:  2000-04       Impact factor: 4.915

4.  An outbreak of invasive fusariosis in a children's cancer hospital.

Authors:  Nadia Litvinov; Mariama Tomaz N da Silva; Inneke M van der Heijden; Mariana G Graça; Larissa Marques de Oliveira; Liang Fu; Mauro Giudice; Maria Zilda de Aquino; Vicente Odone-Filho; Heloisa Helena Marques; Silvia F Costa; Anna S Levin
Journal:  Clin Microbiol Infect       Date:  2014-10-12       Impact factor: 8.067

Review 5.  Burn wound infections.

Authors:  Deirdre Church; Sameer Elsayed; Owen Reid; Brent Winston; Robert Lindsay
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

6.  Clinical and epidemiological aspects of infections caused by fusarium species: a collaborative study from Israel.

Authors:  Ran Nir-Paz; Jacob Strahilevitz; Mervyn Shapiro; Nathan Keller; Anna Goldschmied-Reouven; Oded Yarden; Colin Block; Itzhack Polacheck
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

7.  Fusarium infections in burn patients: a case report and review of the literature.

Authors:  Barbara A Latenser
Journal:  J Burn Care Rehabil       Date:  2003 Sep-Oct

8.  Cutaneous Fusarium solani infection in childhood acute lymphoblastic leukaemia.

Authors:  N S Cooke; C Feighery; D K B Armstrong; M Walsh; S Dempsey
Journal:  Clin Exp Dermatol       Date:  2009-04-27       Impact factor: 3.470

9.  [Fungal infections in a pediatric burn care].

Authors:  María Teresa Rosanova; Hugo Basilico; Mabel Villasboas; Jorge Finquelievich; Andrea Mónaco; Guadalupe Pérez; Griselda Berberian; Verónica Alvarez; Elena Andión; Patricia Santos
Journal:  Arch Argent Pediatr       Date:  2011-10       Impact factor: 0.694

10.  Blood stream infections in patients in the burn intensive care unit.

Authors:  Hun Gu Lee; Juah Jang; Jeong Eun Choi; Doo Cheol Chung; Jung Wan Han; Heungjeong Woo; Wook Jeon; Byung Chul Chun
Journal:  Infect Chemother       Date:  2013-06-26
View more
  6 in total

1.  Fungal Infection in Thermal Burns: A Prospective Study in a Tertiary Care Centre.

Authors:  Sanjeev Sharma; Deepak Bajaj; Pritika Sharma
Journal:  J Clin Diagn Res       Date:  2016-09-01

2.  The Evaluation of Antibiotic Resistance and nalB Mutants in Pseudomonas eruginosa Isolated from Burnt Patients of Shohada Mehrab Yazd Hospital Burn Ward.

Authors:  Seyed Morteza Moosavi; Omid Pouresmaeil; Hengameh Zandi; Sahar Emadi; Fatemeh Akhavan; Alireza Torki; Akram Astani
Journal:  Rep Biochem Mol Biol       Date:  2020-07

3.  Bisifusarium Delphinoides, an Emerging Opportunistic Pathogen in a Burn Patient with Diabetes Mellitus.

Authors:  Ji-Hyun Park; Junsang Oh; Ji-Sun Song; Jayoung Kim; Gi-Ho Sung
Journal:  Mycobiology       Date:  2019-07-01       Impact factor: 1.858

4.  A Rare Case of Fungal Burn Wound Infection Caused by Fusarium solani in Vietnam.

Authors:  Que Anh Tram; Nguyen Thai Ngoc Minh; Do Ngoc Anh; Nguyen Nhu Lam; Tran Ngoc Dung; Ngo Thi Minh Chau; Le Tran-Anh
Journal:  J Investig Med High Impact Case Rep       Date:  2020 Jan-Dec

5.  A rare Fusarium equiseti infection in a 53-year-old male with burn injury: A case report.

Authors:  Tang Xuan Hai; Nguyen Thai Ngoc Minh; Do Ngoc Anh; Tran Ngoc Dung; Ngo Thi Minh Chau; Le Tran-Anh
Journal:  Curr Med Mycol       Date:  2021-03

Review 6.  Viral Infections in Burn Patients: A State-Of-The-Art Review.

Authors:  Jacek Baj; Izabela Korona-Głowniak; Grzegorz Buszewicz; Alicja Forma; Monika Sitarz; Grzegorz Teresiński
Journal:  Viruses       Date:  2020-11-17       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.